상단으로
Seegene participates in LMCE 2016 and the 57th Annual Meeting of the Korean Society for Laboratory Medicine
Nov 04, 2016
Seegene participated in the 2016 Laboratory Medicine Congress and Exhibition (LMCE 2016) and the 57th Annual Meeting of the Korean Society for Laboratory Medicine (KSLM), which was held from October 26 to 28 at The-K Hotel in Seoul, Korea.
The Fall Meeting of the KSLM was expanded to become an international conference from this year and is the first international scientific meeting in the field of laboratory medicine in the Asian region.
About 1,000 in-vitro diagnosis experts from 27 countries including not only Asian countries (Japan, China, Taiwan, Indonesia, etc.) but also the U.S., Australia, France, and the UK participated in this event.
About 1,000 in-vitro diagnosis experts from 27 countries including not only Asian countries (Japan, China, Taiwan, Indonesia, etc.) but also the U.S., Australia, France, and the UK participated in this event.
?
At this year’s congress, Seegene held a luncheon workshop on the results of the evaluation of its Allplex™ Respiratory Panel 1, which recently received licensing from the Ministry of Food and Drug Safety (MFDS) as an in-vitro diagnosis product, as well as Panels 2 and 3, which are in the process of receiving the MFDS marks as well. During the education workshop, one of the programs of the congress, Professor Sung Heungsup of the Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center gave a presentation on the results of the clinical evaluation of Seegene’s Allplex™ Respiratory Panel assays as well as their effectiveness in diagnosing the symptoms of acute respiratory diseases, attracting significant attention from experts in related fields.
?
The Allplex™ Respiratory Panel 1 uses the Multiplex PCR method to rapidly distinguish and test for influenza A/B viruses and RSV A/B while simultaneously testing for subtypes of the influenza A virus. This enables doctors to prescribe the most appropriate anti-viral treatment for each infection.
?
Panels 2, 3, and 4, which test for respiratory viruses and bacteria other than influenza and RSV, received CE certification in 2015 and are currently being supplied to general hospitals and screening centers in Europe. In South Korea, they are in the final stages of the licensing process and will soon be ready for release in the domestic market.
Datenschutz-Präferenz-Center
Unbedingt erforderliche Cookies
Immer aktiv
Diese Cookies sind zur Funktion der Website erforderlich und können in Ihren Systemen nicht deaktiviert werden. In der Regel werden diese Cookies nur als Reaktion auf von Ihnen getätigte Aktionen gesetzt, die einer Dienstanforderung entsprechen, wie etwa dem Festlegen Ihrer Datenschutzeinstellungen, dem Anmelden oder dem Ausfüllen von Formularen. Sie können Ihren Browser so einstellen, dass diese Cookies blockiert oder Sie über diese Cookies benachrichtigt werden. Einige Bereiche der Website funktionieren dann aber nicht.
Funktionale Cookies
Diese Cookies ermöglichen die Bereitstellung erweiterter Funktionalitäten und dienen der Personalisierung. Die Cookies werden insbesondere als Reaktion auf Ihre Aktionen gesetzt und hängen von Ihren konkreten Serviceanfragen (z. B. Einstellung der Sprache) ab.
Analyse- und Marketing Cookies
Wir setzen darüber hinaus auch Analyse- und Marketing-Cookies ein. Dabei handelt es sich um Cookies, die technisch nicht erforderlich sind. Wir setzen diese ein, um Ihr Verhalten auf unserer Website zu verstehen und unser Angebot zu verbessern.